Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Patent
1995-02-15
1996-11-19
Nucker, Christine M.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Amino acid sequence disclosed in whole or in part; or...
4241841, 4242041, 4242071, 4242081, 530350, 5303883, 53038835, 435 5, 435 71, 435974, A61K 3921
Patent
active
055760007
ABSTRACT:
The present invention relates to the HIV-1 strains MN-ST1 and BA-L which are typical United States HIV-1 isotypes. The present invention relates to DNA segments encoding the envelope protein of MN-ST 1 or BA-L, to DNA constructs containing such DNA segments and to host cells transformed with such constructs. The viral isolates and envelope proteins of the present invention are of value for use in vaccines and bioassays for the detection of HIV-1 infection in biological samples, such as blood bank samples.
Franchini Genoveffa
Gallo Robert C.
Gartner Suzanne
Lori Franco C.
Markham Phillip D.
Nucker Christine M.
Stucker Jeffrey
The United States of America as represented by the Department of
LandOfFree
Molecular clones of HIV-1 viral strains MH-ST1 and BA-L, and use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Molecular clones of HIV-1 viral strains MH-ST1 and BA-L, and use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Molecular clones of HIV-1 viral strains MH-ST1 and BA-L, and use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-538847